© Rosalind Scientific LLC 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > “compound 15a”
<< Back to November
reversible ATX inhibitor w/ alt. binding mode
in vivo PD observed on oral dosing
from HTS screen and opt.
Bioorg. Med. Chem. Lett., Nov. 4, 2020
Novartis, Horsham, UK / Basel, CH
“compound 15a” (Novartis reversible in vivo ATX inhibitor)
Unlock this content with a Premium membership to read it now.